Over the past three years, FTC and Department of Justice officials have signaled they would apply more scrutiny to private equity acquisitions in health care.
It’s official: Syneos Health goes private in $7.1B PE deal
The Syneos deal was first announced in May with the unanimous approval of the board of directors and received approval from shareholders in early August.
Why a wave of healthcare agencies may be about to change hands
So-called recapitalizations could accelerate in coming months as pharma commercialization platforms look for new partners with bigger tranches of capital.
Syneos Health shareholders greenlight $7B PE buyout
The deal is expected to be completed in the second half of the year, subject to approval of Syneos Health shareholders as well as other customary closing conditions.
Spectrum Science boards the PE express with funding from Knox Lane